Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.448
+0.034 (8.12%)
At close: Mar 9, 2026, 4:00 PM EDT
0.423
-0.025 (-5.52%)
After-hours: Mar 9, 2026, 5:37 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $37.18 million as of March 9, 2026. Its market cap has decreased by -29.19% in one year.
Market Cap
37.18M
Enterprise Value
62.95M
1-Year Change
-29.19%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $37.18M, a decrease of -61.81%. That is a compound annual growth rate of -9.42%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 37.44M |
| Atara Biotherapeutics | 37.28M |
| Lisata Therapeutics | 36.87M |
| Tvardi Therapeutics | 36.87M |
| PDS Biotechnology | 36.82M |
| NovaBay Pharmaceuticals | 36.31M |
| INmune Bio | 35.36M |
| Celularity | 34.89M |